Moderna generated $2.2B in trailing twelve-month revenue, down 0.3% year-over-year. Net income was -$3.2B with a -143.55% net margin. Gross margin stands at 22.11% and operating margin at -153.35%. Diluted EPS is $-8.15, which grew 0.1% year-over-year. Based on the Q1 2026 filing.